We’re excited to keep you up to date on our activities through announcements, but you can also follow us on our social media channels to hear the latest news as it happens.

   
19 Jul 2022

Idorsia Announces World Champion Skier, Philanthropist and Entrepreneur Lindsey Vonn as Patient Ambassador for QUVIVIQ™ (daridorexant), a Once Nightly Treatment for Insomnia

23 Jun 2022

Idorsia US President Patty Torr was named one of Pharmaceutical Executive’s 2022 Emerging Pharma Leaders among industry peers poised to reshape our industry

06 Jun 2022

SLEEP 2022: Idorsia U.S. to present data from Wake Up America survey, revealing the hidden toll of insomnia, along with three other abstracts on the evaluation and treatment of insomnia

23 May 2022

Idorsia Announces Esteemed Actor, Author and Father, Taye Diggs, as Patient Ambassador for QUVIVIQ™ (daridorexant), a Once Nightly Treatment for Insomnia

13 May 2022

Idorsia U.S. Announces First Wave of Patients Prescribed QUVIVIQ (daridorexant) through Partnership with Pharmacy Services Provider

02 May 2022

Idorsia’s new treatment QUVIVIQ (daridorexant) is now available in the US for adults living with insomnia

05 Apr 2022

Results Announced from Largest U.S. Survey of People with Trouble Sleeping, as well as Doctors, to Better Understand the Hidden Toll of Insomnia

16 Mar 2022

World Premiere: The Quest for Sleep, a Film Narrated by Octavia Spencer, Explores People’s Struggles with Insomnia and the Fascinating Science Behind How and Why We Sleep

20 Jan 2022

The Lancet Neurology reports impact of daridorexant in insomnia

12 Jan 2022 Jennifer Aniston partners with Idorsia U.S. to launch ‘Seize the Night & Day’ campaign inspiring Americans to understand their relationship with sleep
10 Jan 2022 Idorsia receives US FDA approval of QUVIVIQ (daridorexant) 25 and 50 mg for the treatment of adults with insomnia
17 Nov 2021 Idorsia Convenes The Alliance for Sleep, a Force for Innovation and Change in the Insomnia Space